Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1985 May;75(5):513–517. doi: 10.2105/ajph.75.5.513

Neurologic dysfunction from exposure to 2-t-butylazo-2-hydroxy-5-methylhexane (BHMH): a new occupational neuropathy.

J M Horan, T L Kurt, P J Landrigan, J M Melius, M Singal
PMCID: PMC1646263  PMID: 3985240

Abstract

Seven cases of subacute central and peripheral neurologic dysfunction developed in 18 workers employed in the manufacture of reinforced plastic bathtubs. Cases were characterized by weight loss, dizziness, paresthesias, muscle weakness, incontinence, memory loss, and loss of peripheral, color, and night vision. Neuropathies began distally, involved both sensory and motor function, and were associated with prolonged sensory latency, muscle fibrillation, and reduced numbers of functioning motor units. One patient developed posterior lenticular cataracts. Slow improvement occurred on removal from exposure, but residual neuropathies persisted for as long as two years. Epidemiologic investigation disclosed that the first case developed approximately two weeks after introduction of a new plastic foaming agent, 2-t-butylazo-2-hydroxy-5-methylhexane (BHMH). All cases occurred in workers exposed directly to BHMH. No new cases developed after use of BHMH was discontinued. A survey of the firm which produced BHMH and of 68 user firms found two additional clusters of mild neuropathy which may have been caused by BHMH. BHMH was withdrawn from distribution following discovery of these cases. Subsequently, BHMH has been shown in rats to be a potent neurotoxin. Adequate premarket testing could have averted this outbreak.

Full text

PDF
513

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altenkirch H., Stoltenburg G., Wagner H. M. Experimental studies on hydrocarbon neuropathies induced by methyl-ethyl-ketone (MEK). J Neurol. 1978 Dec 7;219(3):159–170. doi: 10.1007/BF00314531. [DOI] [PubMed] [Google Scholar]
  2. BERKLEY M. C., MAGEE K. R. Neuropathy following exposure to a dimethylamine salt of 2, 4-D. Arch Intern Med. 1963 Mar;111:351–352. doi: 10.1001/archinte.1963.03620270077012. [DOI] [PubMed] [Google Scholar]
  3. Billmaier D., Allen N., Craft B., Williams N., Epstein S., Fontaine R. Peripheral neuropathy in a coated fabrics plant. J Occup Med. 1974 Oct;16(10):665–671. [PubMed] [Google Scholar]
  4. Cannon S. B., Veazey J. M., Jr, Jackson R. S., Burse V. W., Hayes C., Straub W. E., Landrigan P. J., Liddle J. A. Epidemic kepone poisoning in chemical workers. Am J Epidemiol. 1978 Jun;107(6):529–537. doi: 10.1093/oxfordjournals.aje.a112572. [DOI] [PubMed] [Google Scholar]
  5. Cavanagh J. B. Toxic substances and the nervous system. Br Med Bull. 1969 Sep;25(3):268–273. doi: 10.1093/oxfordjournals.bmb.a070716. [DOI] [PubMed] [Google Scholar]
  6. Davis D. L., Magee B. H. Cancer and industrial chemical production. Science. 1979 Dec 21;206(4425):1356–1358. doi: 10.1126/science.505010. [DOI] [PubMed] [Google Scholar]
  7. Garland T. O., Patterson M. W. Six cases of acrylamide poisoning. Br Med J. 1967 Oct 28;4(5572):134–138. doi: 10.1136/bmj.4.5572.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Herskowitz A., Ishii N., Schaumburg H. N-hexane neuropathy. A syndrome occurring as a result of industrial exposure. N Engl J Med. 1971 Jul 8;285(2):82–85. doi: 10.1056/NEJM197107082850204. [DOI] [PubMed] [Google Scholar]
  9. Jenkins R. B. Inorganic arsenic and the nervous system. Brain. 1966 Sep;89(3):479–498. doi: 10.1093/brain/89.3.479. [DOI] [PubMed] [Google Scholar]
  10. Kreiss K., Wegman D. H., Niles C. A., Siroky M. B., Krane R. J., Feldman R. G. Neurological dysfunction of the bladder in workers exposed to dimethylaminopropionitrile. JAMA. 1980 Feb 22;243(8):741–745. [PubMed] [Google Scholar]
  11. Landrigan P. J., Kreiss K., Xintaras C., Feldman R. G., Heath C. W., Jr Clinical epidemiology of occupational neurotoxic disease. Neurobehav Toxicol. 1980 Spring;2(1):43–48. [PubMed] [Google Scholar]
  12. Rosén I., Haeger-Aronsen B., Rehnström S., Welinder H. Neurophysiological observations after chronic styrene exposure. Scand J Work Environ Health. 1978;4 (Suppl 2):184–194. [PubMed] [Google Scholar]
  13. Saida K., Mendell J. R., Weiss H. S. Peripheral nerve changes induced by methyl n-butyl ketone and potentiation by methyl ethyl ketone. J Neuropathol Exp Neurol. 1976 May;35(3):207–225. doi: 10.1097/00005072-197605000-00001. [DOI] [PubMed] [Google Scholar]
  14. Seppäläinen A. M., Hernberg S. Subclinical lead neuropathy. Am J Ind Med. 1980;1(3-4):413–420. doi: 10.1002/ajim.4700010319. [DOI] [PubMed] [Google Scholar]
  15. Seppäläinen A. M., Härkönen H. Neurophysiological findings among workers occupationally exposed to styrene. Scand J Work Environ Health. 1976 Sep;2(3):140–146. doi: 10.5271/sjweh.2810. [DOI] [PubMed] [Google Scholar]
  16. Spencer P. S., Schaumburg H. H. Experimental neuropathy produced by 2,5-hexanedione--a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone. J Neurol Neurosurg Psychiatry. 1975 Aug;38(8):771–775. doi: 10.1136/jnnp.38.8.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. VIGLIANI E. C. Carbon disulphide poisoning in viscose rayon factories. Br J Ind Med. 1954 Oct;11(4):235–244. doi: 10.1136/oem.11.4.235. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES